Influence of Pertussis Toxin Pretreatment on the Development of L-NAME-Induced Hypertension

被引:4
|
作者
Zicha, J. [1 ,2 ]
Kunes, J. [1 ,2 ]
Vrankova, S. [3 ]
Jendekova, L. [3 ]
Dobesova, Z. [1 ,2 ]
Pinterova, M. [1 ,2 ]
Pechanova, O. [1 ,3 ]
机构
[1] Acad Sci Czech Republ, Inst Physiol, Videnska 1083, CR-14220 Prague 4, Czech Republic
[2] Cardiovasc Res Ctr, Prague, Czech Republic
[3] Slovak Acad Sci, Inst Normal & Pathol Physiol, Bratislava, Slovakia
关键词
Sympathetic nervous system; Nitric oxide; Inhibitory G proteins; Blood pressure; NITRIC-OXIDE; ENHANCED EXPRESSION; BLOOD-PRESSURE; MECHANISMS; CAPTOPRIL; PROTEINS; BRAIN;
D O I
10.33549/physiolres.931898
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
High blood pressure (BP) of L-NAME hypertensive rats is maintained not only by the absence of nitric oxide (NO)dependent vasodilatation but also by the enhancement of both sympathetic and angiotensin II-dependent vasoconstriction. The aim of the present study was to evaluate the role of inhibitory G (G(i)) proteins, which are involved in tonic sympathetic vasoconstriction, in the pathogenesis of NO-deficient hypertension. We therefore studied BP response to chronic L-NAME administration (60 mg/kg/day for 4 weeks) in rats in which the in vivo inactivation of Gi proteins was induced by injection of pertussis toxin (PTX, 10 mu g/kg i.v.). The impairment of sympathetic vasoconstriction due to PTX-induced G(i) protein inactivation prevents the full development of NO-deficient hypertension because BP of PTX-treated rats subjected to chronic L-NAME administration did not reach hypertensive values. Nevertheless, chronic NO synthase inhibition per se is capable to increase moderately BP even in PTX-treated rats. Our data suggest that the sympathetic vasoconstriction is essential for the development of established NO-deficient hypertension.
引用
收藏
页码:751 / 755
页数:5
相关论文
共 50 条
  • [41] L-Arginine fails to protect against myocardial remodelling in L-NAME-induced hypertension
    Simko, F
    Luptak, I
    Matuskova, J
    Krajcirovicova, K
    Sumbalova, Z
    Kucharska, J
    Gvozdjakova, A
    Simko, J
    Babal, P
    Pechanova, O
    Bernatova, I
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2005, 35 (06) : 362 - 368
  • [42] Heme-L-arginate therapy suppresses angiotensin levels in L-name-induced hypertension
    Lane, N.
    Ndisang, J.
    CANADIAN JOURNAL OF CARDIOLOGY, 2007, 23 : 246C - 246C
  • [43] The Role of Inflammatory Markers in the Cardioprotective Effect of L-Carnitine in L-NAME-Induced Hypertension
    Miguel-Carrasco, Jose L.
    Mate, Alfonso
    Monserrat, Maria T.
    Arias, Jose L.
    Aramburu, Oscar
    Vazquez, Carmen M.
    AMERICAN JOURNAL OF HYPERTENSION, 2008, 21 (11) : 1231 - 1237
  • [44] Genetic control of susceptibility to glomerular damage in rats with L-NAME-induced hypertension.
    VanDookum, RPE
    Jacob, JH
    Provoost, AP
    KIDNEY INTERNATIONAL, 1997, 52 (02) : 566 - 566
  • [45] Effect of Melatonin on the Renin-Angiotensin-Aldosterone System in L-NAME-Induced Hypertension
    Simko, Fedor
    Baka, Tomas
    Krajcirovicova, Kristina
    Repova, Kristina
    Aziriova, Silvia
    Zorad, Stefan
    Poglitsch, Marko
    Adamcova, Michaela
    Reiter, Russel J.
    Paulis, Ludovit
    MOLECULES, 2018, 23 (02):
  • [46] Resistance Training Controls Arterial Blood Pressure in Rats with L-NAME-Induced Hypertension
    Santos de Araujo, Ayslan Jorge
    Verissimo dos Santos, Anne Carolline
    Souza, Karine dos Santos
    Aires, Marlucia Bastos
    Santana-Filho, Valter Joviniano
    Fioretto, Emerson Ticona
    Mota, Marcelo Mendonca
    Viana Santos, Marcio Roberto
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2013, 100 (04) : 339 - 346
  • [47] Novel diallyldisulfide analogs ameliorate cardiovascular remodeling in rats with L-NAME-induced hypertension
    Sharma, Dinesh Kumar
    Manral, Apra
    Saini, Vikas
    Singh, Avninder
    Srinivasan, B. P.
    Tiwari, Manisha
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2012, 691 (1-3) : 198 - 208
  • [48] Ameliorative effects of Moringa oleifera (MO) seeds on L-NAME-induced hypertension in rats
    Omobowale, Temidayo
    Oyagbemi, Ademola
    Aderoju, Abiodun
    Adejumobi, Olumuyiwa
    Adedapo, Adeolu
    Gbadamosi, Idayat
    Yakubu, Momoh
    FASEB JOURNAL, 2020, 34
  • [49] Antioxidant and vascular protective effects of curcumin and tetrahydrocurcumin in rats with L-NAME-induced hypertension
    Nakmareong, Saowanee
    Kukongviriyapan, Upa
    Pakdeechote, Poungrat
    Donpunha, Wanida
    Kukongviriyapan, Veerapol
    Kongyingyoes, Bunkerd
    Sompamit, Kwanjit
    Phisalaphong, Chada
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2011, 383 (05) : 519 - 529
  • [50] 5-Lipoxagenase deficiency attenuates L-NAME-induced hypertension and vascular remodeling
    Chen, Jia-xiang
    Xue, Kun-yue
    Xin, Juan-juan
    Yan, Xin
    Li, Ru-Li
    Wang, Xiao-Xiao
    Wang, Xu-Lei
    Tong, Ming-ming
    Gan, Lu
    Li, He
    Lan, Jie
    Li, Xue
    Zhuo, Cai-li
    Li, Ling-yu
    Deng, Zi-jie
    Zhang, Heng-Yu
    Jiang, Wei
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2019, 1865 (09): : 2379 - 2392